Trial Details
RECRUITINGBasic Information
| Clinical ID | c1123 |
|---|---|
| Identifier | NCT06582264 |
| Trial Title | A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: MB310|OTHER: Placebo|DRUG: Vancomycin |
Participant Information
| Sponsor | Microbiotica Ltd |
|---|---|
| City | Innsbruck |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2024-09-27 |
|---|---|
| Primary Completion Date | 2025-12-25 |
| Completion Date | 2025-12-25 |